NeuroMetrix, Inc. (NASDAQ:NURO – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 2,700 shares, a drop of 87.4% from the December 31st total of 21,400 shares. Based on an average trading volume of 21,200 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.2% of the shares of the company are sold short.
NeuroMetrix Price Performance
Shares of NURO traded down $0.02 during midday trading on Tuesday, reaching $4.19. The stock had a trading volume of 8,956 shares, compared to its average volume of 19,833. The firm’s 50 day moving average price is $4.04 and its 200-day moving average price is $3.89. The company has a market capitalization of $8.55 million, a P/E ratio of -0.91 and a beta of 2.20. NeuroMetrix has a 52 week low of $2.66 and a 52 week high of $4.73.
NeuroMetrix (NASDAQ:NURO – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The medical device company reported ($0.75) earnings per share for the quarter. NeuroMetrix had a negative net margin of 203.71% and a negative return on equity of 42.56%. The business had revenue of $0.59 million for the quarter. During the same period last year, the business posted ($1.66) EPS.
Wall Street Analyst Weigh In
Read Our Latest Research Report on NURO
About NeuroMetrix
NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.
See Also
- Five stocks we like better than NeuroMetrix
- EV Stocks and How to Profit from Them
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- 5 discounted opportunities for dividend growth investors
- What Does the Future Hold for Eli Lilly?
- 10 Best Airline Stocks to Buy
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for NeuroMetrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix and related companies with MarketBeat.com's FREE daily email newsletter.